Even Five Years Postapproval, Many Drug Studies Remain Nonpublic

FRIDAY, Sept. 1, 2023 -- Only a fraction of evidence from completed studies is available publicly before drugs receive U.S. Food and Drug Administration approval, according to a study published in the August issue of Health Affairs Scholar.
Robert...